San Francisco Sentry Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $4K | Hold |
22
| – | – | ﹤0.01% | 596 |
|
|
2021
Q1 | $5K | Hold |
22
| – | – | ﹤0.01% | 602 |
|
|
2020
Q4 | $5K | Hold |
22
| – | – | ﹤0.01% | 568 |
|
|
2020
Q3 | $6K | Hold |
22
| – | – | ﹤0.01% | 525 |
|
|
2020
Q2 | $6K | Sell |
22
-22
| -50% | -$6K | ﹤0.01% | 526 |
|
|
2020
Q1 | $10K | Hold |
44
| – | – | 0.01% | 480 |
|
|
2019
Q4 | $10K | Sell |
44
-122
| -73% | -$27.7K | ﹤0.01% | 558 |
|
|
2019
Q3 | $28K | Sell |
166
-74
| -31% | -$12.5K | 0.01% | 437 |
|
|
2019
Q2 | $44K | Hold |
240
| – | – | 0.02% | 382 |
|
|
2019
Q1 | $44K | Sell |
240
-40
| -14% | -$7.33K | 0.02% | 396 |
|
|
2018
Q4 | $46K | Sell |
280
-21
| -7% | -$3.45K | 0.02% | 371 |
|
|
2018
Q3 | $58K | Sell |
301
-804
| -73% | -$155K | 0.02% | 370 |
|
|
2018
Q2 | $188K | Sell |
1,105
-1
| -0.1% | -$170 | 0.08% | 214 |
|
|
2018
Q1 | $180K | Buy |
1,106
+800
| +261% | +$130K | 0.05% | 288 |
|
|
2017
Q4 | $46K | Buy |
306
+94
| +44% | +$14.1K | 0.01% | 463 |
|
|
2017
Q3 | $32K | Sell |
212
-42
| -17% | -$6.34K | 0.01% | 488 |
|
|
2017
Q2 | $33K | Buy |
+254
| New | +$33K | 0.01% | 405 |
|
|
2014
Q3 | – | Sell |
-141
| Closed | -$13K | – | 654 |
|
|
2014
Q2 | $13K | Sell |
141
-72
| -34% | -$6.64K | 0.01% | 454 |
|
|
2014
Q1 | $15K | Hold |
213
| – | – | ﹤0.01% | 480 |
|
|
2013
Q4 | $16K | Hold |
213
| – | – | 0.01% | 449 |
|
|
2013
Q3 | $16K | Hold |
213
| – | – | 0.01% | 425 |
|
|
2013
Q2 | $17K | Buy |
+213
| New | +$17K | 0.01% | 426 |
|